Loading organizations...
The Coalition for Epidemic Preparedness Innovations (CEPI) operates as a global partnership dedicated to accelerating the development of vaccines and other biologic countermeasures. It focuses on addressing epidemic and pandemic threats, employing innovative and access-focused research and development programs to significantly reduce global public health risks. Its core capability lies in funding and coordinating the creation of new vaccines against emerging infectious diseases, enhancing the world's ability to respond quickly to health crises.
CEPI was conceived in 2015 and formally launched in 2017 at the World Economic Forum in Davos, Switzerland. It emerged from the critical insight that a proactive, collaborative approach was necessary to develop vaccines swiftly and equitably in response to potential outbreaks. The organization was co-founded by the governments of India and Norway, the Bill & Melinda Gates Foundation, Wellcome, and the World Economic Forum, reflecting a broad public-private commitment to global health security.
Ultimately, CEPI serves the global population, particularly those vulnerable to emerging infectious diseases, by fostering a more prepared world. Its long-term vision is to substantially mitigate epidemic and pandemic risk, striving to create a safer planet by ensuring the rapid availability of effective medical interventions. The organization envisions a future where the world is no longer caught off guard by novel pathogens, thereby preventing widespread illness and societal disruption.
Key people at Coalition for Epidemic Preparedness Innovations.
Coalition for Epidemic Preparedness Innovations has 1 tracked investment across 1 company. The latest tracked deal is $1.1M Seed in Apriori Bio in July 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 8, 2024 | Apriori Bio | $1.1M Seed | Coalition For Epidemic Preparedness Innovations | — |
Key people at Coalition for Epidemic Preparedness Innovations.